Tema Oncology ETFCANCETF
13F holders, Q2 2024 (June 30)4holders +1
1new positions
0sold out
$26.98avg. 13F price*
At the end of Q2 2024, 4 institutions reported holding Tema Oncology ETF (CANC) in their 13F filings, up 1 from Q1 2024. 1 opened new positions and 0 sold out. The largest holders were Thrivent Financial for Lutherans ($8.6M), Jane Street Group, LLC ($3.9M) and Harbour Investments, Inc. ($9K).
- Company
- Tema Oncology ETF
- Filed as
- TEMA ETF TRUST (Q2 2024)
- CUSIP
- 87975E701
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $8.6M |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 454,548 shares bought, net +454,548 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Thrivent Financial for Lutherans | 0.02% | New | 319,376 | $8.6M |
| Jane Street Group, LLC | 0.00% | Add +1685.7% | 143,191 | $3.9M |
| Harbour Investments, Inc. | 0.00% | No change | 316 | $9K |
| Osaic Holdings, Inc. | 0.00% | No change | 200 | $5K |
"% of holder's portfolio" is CANC's weight in each manager's 13F, not the share of Tema Oncology ETF the manager owns.